Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07758426
Effects of Tummy Time Associated With Therapeutic Positioning in Premature Newborns With Cranial AsymmetryHospital de Clinicas de Porto AlegreNot Yet RecruitingNot Applicable
NCT07758426Not Yet Recruiting
Not Applicable
Effects of Tummy Time Associated With Therapeutic Positioning in Premature Newbo...Hospital de Clinicas de P...
NCT07758855
Nanotechnological Silver-Coated Dressing in Diabetic Foot UlcersAnkara City Hospital BilkentCompletedNot Applicable
NCT07758855Completed
Not Applicable
Nanotechnological Silver-Coated Dressing in Diabetic Foot UlcersAnkara City Hospital Bilk...
NCT07758348
Investigating Modulation of Neuropathic Pain by Transcranial Magnetic Stimulation: a Multimodal Imaging and Electrophysiological ApproachNational Taiwan University HospitalNot Yet RecruitingNot Applicable
NCT07758348Not Yet Recruiting
Not Applicable
Investigating Modulation of Neuropathic Pain by Transcranial Magnetic Stimulatio...National Taiwan Universit...
NCT07759050
Clinical Study of Spectral CTPhilips Clinical & Medical Affairs GlobalNot Yet RecruitingNot Applicable
NCT07759050Not Yet Recruiting
Not Applicable
Clinical Study of Spectral CTPhilips Clinical & Medica...
NCT07758413
Pilot RCT of a Chinese Medicine Diabetes Education ProgrammeThe Hong Kong Polytechnic UniversityNot Yet RecruitingNot Applicable
NCT07758413Not Yet Recruiting
Not Applicable
Pilot RCT of a Chinese Medicine Diabetes Education ProgrammeThe Hong Kong Polytechnic...
NCT07756918
Effects of Extracorporeal Shockwave Therapy Versus Dry Needling on Jumpers KneeRiphah International UniversityRecruitingNot Applicable
NCT07756918Recruiting
Not Applicable
Effects of Extracorporeal Shockwave Therapy Versus Dry Needling on Jumpers KneeRiphah International Univ...
NCT07758127
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology CenterNot Yet Recruiting
NCT07758127Not Yet Recruiting
—
Updates and Insights on HER2 in Breast Cancer in Sohag GovernorateSohag Oncology Center
NCT07758387
Polydextrose Functional Gummies for Weight Management in Adults With Overweight or ObesityNutris We Care About You S.L.Not Yet RecruitingNot Applicable
NCT07758387Not Yet Recruiting
Not Applicable
Polydextrose Functional Gummies for Weight Management in Adults With Overweight...Nutris We Care About You...
NCT07758868
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City HospitalNot Yet Recruiting
NCT07758868Not Yet Recruiting
—
Residual Neuromuscular Blockade and PACU AdmissionAnkara Etlik City Hospita...
NCT07757555
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia InternationalNot Yet RecruitingEarly Phase 1
NCT07757555Not Yet Recruiting
Early Phase 1
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialDysautonomia Internationa...
NCT07758569
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Glaucoma in a Random Sample of Retinal Fundus PhotographsDemocritus University of ThraceRecruiting
NCT07758569Recruiting
—
Validation of the Artificial Intelligence Subsystem of the DDART Medical Device...Democritus University of...
NCT07757672
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.Institute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingPhase 1
NCT07757672Not Yet Recruiting
Phase 1
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine,...Institute of Hematology &...
NCT07758985
Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali.London School of Hygiene and Tropical MedicineNot Yet RecruitingPhase 1
NCT07758985Not Yet Recruiting
Phase 1
Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner...London School of Hygiene...
NCT07758920
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic NeuralgiaShanghai Yidian Pharmaceutical Technology Development Co., Ltd.RecruitingPhase 2
NCT07758920Recruiting
Phase 2
A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Tr...Shanghai Yidian Pharmaceu...
NCT07757906
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal DissectionQilu Hospital of Shandong UniversityNot Yet RecruitingNot Applicable
NCT07757906Not Yet Recruiting
Not Applicable
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADT...Qilu Hospital of Shandong...
NCT07758816
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Research CollaborationRecruiting
NCT07758816Recruiting
—
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Rese...
NCT07757204
An Open-label Long-term Safety Study of Buntanetap in Participants With ADAnnovis Bio Inc.Not Yet RecruitingPhase 2
NCT07757204Not Yet Recruiting
Phase 2
An Open-label Long-term Safety Study of Buntanetap in Participants With ADAnnovis Bio Inc.
NCT07757828
Efficacy of PRF in Hypospadias RepairAin Shams UniversityNot Yet RecruitingNot Applicable
NCT07757828Not Yet Recruiting
Not Applicable
Efficacy of PRF in Hypospadias RepairAin Shams University
NCT07758075
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque PsoriasisGuangdong Hengrui Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07758075Not Yet Recruiting
Phase 2
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Inject...Guangdong Hengrui Pharmac...
NCT07757958
Partial Breast Irradiation Without Sentinel Lymph Node Biopsy in Low-Risk Early Breast CancerNational Institute of Health, KoreaNot Yet RecruitingPhase 3
NCT07757958Not Yet Recruiting
Phase 3
Partial Breast Irradiation Without Sentinel Lymph Node Biopsy in Low-Risk Early...National Institute of Hea...
Result Breakdown
Not yet recruiting15 (75%)
Recruiting4 (20%)
Completed1 (5%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 12 (10%)
Early Phase 11 (5%)
Phase 31 (5%)